These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2665960)

  • 1. A biologically active insulin analogue with modification in the A2 position. [2-Valine-A] sheep insulin.
    Ohta N; Burke GT; Katsoyannis PG
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):670-4. PubMed ID: 2665960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
    Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin.
    Chu YC; Burke GT; Ross JB; Katsoyannis PG
    J Protein Chem; 1993 Aug; 12(4):499-505. PubMed ID: 8251071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
    Ohta N; Burke GT; Katsoyannis PG
    J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of the A2 amino acid residue in the biological activity of insulin: [2-glycine-A]- and [2-alanine-A]insulins.
    Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1984 Mar; 23(7):1405-13. PubMed ID: 6372857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC; Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
    Nakagawa SH; Tager HS; Steiner DF
    Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence of a New World primate insulin having low biological potency and immunoreactivity.
    Seino S; Steiner DF; Bell GI
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7423-7. PubMed ID: 3118367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
    Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
    Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(A1-D-alanine) insulin (author's transl)].
    Geiger R; Geisen K; Summ HD; Langer D
    Hoppe Seylers Z Physiol Chem; 1975 Oct; 356(10):1635-49. PubMed ID: 1213677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superactive insulins.
    Burke GT; Hu SQ; Ohta N; Schwartz GP; Zong L; Katsoyannis PG
    Biochem Biophys Res Commun; 1990 Dec; 173(3):982-7. PubMed ID: 2268358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
    Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
    J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin.
    Chu YC; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6972-5. PubMed ID: 3322394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulin.
    Schwartz GP; Burke GT; Katsoyannis PG
    Int J Pept Protein Res; 1981 Feb; 17(2):243-55. PubMed ID: 7014485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PHARMACEUTICAL AND CHEMICAL STUDIES ON INSULIN. (30) ON N-TERMINAL AMINO ACIDS AND CHEMICAL STRUCTURES OF BONITO AND TUNNY FISH INSULINS PURIFIED BY PRECIPITATION AT ISOELECTRIC POINT].
    NISHIZAKI S
    Eisei Shikenjo Hokoku; 1963 Oct; 81():30-3. PubMed ID: 14162026
    [No Abstract]   [Full Text] [Related]  

  • 17. [A2-Norleucine]insulin. An analog with unanticipated biological properties.
    Okada Y; Chanley JD; Burke GT; Katsoyannis PG
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):629-38. PubMed ID: 7024085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin analogues with permuted A chain N-terminus (author's transl)].
    Krail G; Brandenburg D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):981-96. PubMed ID: 1181282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.